AHF Podcast

Anterior Hip Foundation
  • 0,0 (0)
  • MEDICINA
  • SEMANALMENTE

The AHF Podcast features thoughtful conversations about orthopedic surgery, outcomes, and clinical decision-making, with a particular focus on hip surgery and related innovation.Produced by the Anterior Hip Foundation, the podcast brings together surgeons, researchers, and clinical leaders to examine how evidence, experience, and real-world practice intersect. Episodes explore what the data actually shows, where assumptions break down, and how clinicians navigate uncertainty in daily practice.This podcast is intended for orthopedic surgeons, trainees, and medically literate clinicians who value nuanced discussion, critical thinking, and honest examination of what improves patient care.

  1. -1 DIA

    From Idea to Market: Ep 7 - Beyond Clearance

    Send us Fan Mail Your device just got FDA clearance. So why isn't anyone using it? In this episode of From Idea to Market, Joe Schwab and a panel of surgeons, engineers, and MedTech leaders explore why regulatory approval is only the beginning — and what it actually takes to earn a place in the operating room. Clearance tells you a device is safe and effective. It doesn't tell you whether a busy surgeon will change their workflow, whether a procurement committee will approve it, or whether a hospital can absorb it into daily practice. This episode unpacks the gap between permission and performance — the space where most MedTech innovations either earn trust or stall out. Drawing on Everett Rogers' Diffusion of Innovations theory and recent research on early adoption decision-making in surgery, the conversation examines why clinical evidence alone isn't enough. Guests describe how simplicity, immediate benefit, team dynamics, and peer influence determine whether a technology sticks — and why the intention-behavior gap in surgical practice is wider than most companies expect. The panel also explores how success is redefined after clearance, moving from trial endpoints to real-world outcomes including patient satisfaction, complication rates, workflow efficiency, and health economics. In the PJI space alone, annual hospital costs are projected to reach $1.85 billion by 2030, giving technologies that move the needle enormous clinical and economic significance. ⏱️ Chapters: 00:00 Introduction and series overview 02:34 Meet the panel 05:47 Why clearance is only the beginning 07:42 Diffusion of innovations in surgery 11:07 Investing in data vs inventory after clearance 16:11 The intention-behavior gap in adoption 18:14 Deliberate rollout and early adopter strategy 20:55 Simplicity as the key to surgical adoption 23:18 Market forces behind technology uptake 26:19 Redefining success outside controlled settings 29:24 PJI economics and the case for innovation 33:19 When innovation becomes the standard of care 36:52 Three lessons from life after clearance Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #MedTechAdoption #RegulatoryStrategy #FDAClearance #DiffusionOfInnovations #SurgicalInnovation #TotalHipArthroplasty #PJI #PeriprostheticJointInfection #RealWorldEvidence #OrthopedicSurgery #FromIdeaToMarket #MedicalDeviceAdoption

    40 min

  2. -4 DIAS

    FITM Extended Interview: Charlie DeCook

    Send us Fan Mail Charlie DeCook has exited seven medical device companies while performing 1,500 joint replacements a year — all packed into three clinical days per week. In this extended interview, he breaks down exactly how he evaluates new technologies and why he now filters every opportunity through an AI and robotics lens. DeCook traces his entrepreneurial arc from his first venture in surgical impaction — a product that eventually sold to Johnson & Johnson and became Kincise — through to his current focus on software-driven solutions. He explains why the "jobs to be done" framework from Clayton Christensen's Innovator's Dilemma is the foundation of every product he touches, and why surgeons who skip the financial model are setting themselves up for years of pain. Along the way, he offers a candid look at how large device companies operate, including the "slow no" that strings inventor-surgeons along for months without a real commitment. The conversation also covers the AHF Shark Tank program and what separates pitches that land from those that get eaten alive. Whether you are a surgeon sitting in the OR frustrated with an inefficiency, or a founder trying to get traction with the big three, DeCook's hard-won playbook is worth hearing in full. ⏱️ Chapters: 00:00 Meet Charlie DeCook — surgeon, serial entrepreneur 02:11 First venture: surgical impaction to Johnson & Johnson 03:29 Filtering ideas with easier, faster, better 05:22 Patient outcomes vs commercial reality in med-tech 07:43 Why cost concerns work themselves out over time 09:02 Strategic shift from hardware to AI and robotics 10:41 Finding innovation through jobs to be done in the OR 12:43 Lessons from ventures that required major pivots 14:49 Protecting IP from large device companies 17:27 Why public companies can't think past the quarter 19:02 Evaluating products beyond your own efficiency lens 21:40 What makes a winning AHF Shark Tank pitch 24:29 Common mistakes surgeon-entrepreneurs make pitching 27:17 Innovation areas the Shark Tank needs more of 29:25 Top advice for surgeons with a great OR idea 31:45 What innovation in orthopedics really means Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #SurgeonEntrepreneur #MedicalDeviceStartup #OrthopedicInnovation #TotalJointArthroplasty #SurgicalImpaction #AIinOrthopedics #RoboticSurgery #JobsToBeDone #AHFSharkTank #CharlieDeCook #MedTechEntrepreneur #THA

    30 min

  3. 10/04

    From Idea to Market: Ep 6 - The Valley Between Idea and Approval

    Send us Fan Mail What actually happens between building a medical device and getting it approved? In this episode of From Idea to Market, we walk through the regulatory valley that separates a working prototype from a cleared product — and why so many promising innovations stall right here. This is the stage where progress stops being about what you can build and starts being about what you can prove. Joe Schwab breaks down the FDA's device classification system, the critical difference between 510(k) and PMA pathways, and why the gap between regulatory clearance and reimbursement has become one of the defining challenges in modern med tech. You'll hear from founders and industry veterans — including Jared Foran, Peter Noymer, Doug Fairbanks, Marie-Isabelle Batthyány, Robert Cohen, and Simon Mifsud — who share hard-won lessons about navigating this process with limited capital and no margin for error. Whether you're a surgeon with a device idea, an engineer entering the med tech space, or an investor trying to understand what makes regulatory risk so difficult to price, this episode maps the valley in concrete terms — and explains why the teams that survive it tend to build better products because of it. ⏱️ Chapters: 00:00 Introduction to the regulatory valley 02:21 Meet the founders and industry veterans 04:36 Why promising devices stall before FDA review 05:23 FDA device classification for hip arthroplasty 09:10 Designing to regulatory standards from day one 10:26 FDA clearance without reimbursement 14:07 How design controls sharpen device claims 16:32 FDA designations that accelerate development 19:56 Costs and risks founders underestimate 23:31 Three lessons from the regulatory valley Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #FDAApproval #MedicalDeviceRegulation #510k #PMA #TotalHipArthroplasty #MedTechInnovation #DeviceClassification #DesignControls #Reimbursement #OrthopedicSurgery #ValleyOfDeath #FromIdeaToMarket

    27 min

  4. 7/04

    FITM: The Extended Conversation with Doug Fairbanks

    Send us Fan Mail Doug Fairbanks left a robotics commercialization role at Johnson & Johnson to lead a deep tech startup most surgeons had never heard of. In this conversation, the president and CEO of VISIE Inc. explains why — and what their continuous anatomic auto tracking technology could mean for the future of robotic-assisted surgery. VISIE started as Advanced Scanners, a company founded by optical physicist Aaron Bernstein to solve the problem of brain shift during cranial procedures. Fairbanks saw the technology's potential far beyond neuroscience and joined to steer the company toward orthopedics. The result is a 3D spatial computing platform that tracks anatomy in real time at 254-micron accuracy — without pins, arrays, or registration. Fairbanks walks through how VISIE built all its hardware and software in-house to push the limits of what's possible, why that Apollo 13 engineering mentality defines the company's culture, and what it took to go from four scans per second to over twenty-five. This episode also covers the business side of deep tech innovation: how VISIE navigates the sub-component regulatory pathway, what partnership conversations with strategic companies actually sound like, how 16 patents in eight months shaped their IP strategy, and why the board in the other room still reads “patients treated: zero.” Whether you're a surgeon curious about pin-free tracking or a founder building something no one has built before, this is a candid look at what it takes to bring genuinely new technology to the operating room. Learn more about VISIE at https://visievision.com ⏱️ Chapters: 00:00 From neuroscience startup to surgical vision company 03:55 Launching Velys robotics at DePuy Synthes 07:44 What is continuous anatomic auto tracking 11:07 Why VISIE builds all hardware and software in-house 13:54 Teaching robots to see what surgeons see 18:30 The hardest technical challenge at VISIE 21:00 Validating deep tech with the surgical market 25:42 Scaling a startup with contract manufacturing 28:09 Regulatory pathway as a sub-component device 32:00 Protecting innovation with an aggressive IP strategy 35:09 Future of pin-free tracking in hips and knees 37:29 Advice for surgeon innovators starting a company Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #VISIE #DougFairbanks #PinFreeTracking #SurgicalRobotics #3DScanning #CAAT #OrthopedicInnovation #MedTechStartup #RoboticAssistedSurgery #ComputerVision #SpatialComputing

    43 min

  5. 3/04

    From Idea to Market: Ep 5 - Financing the Journey

    Send us Fan Mail Most MedTech founders think financing is about getting enough money to keep building. But once you take capital, it reshapes your governance, your priorities, and your pace — and some consequences don't surface for years. In this episode of the AHF Podcast's From Idea to Market series, we explore what funding actually buys beyond time and resources, how capital decisions redistribute power within a startup, and which financing consequences only become visible years later. Founders, investors, and legal experts share hard-won lessons about navigating the Valley of Death — from choosing between equity and grants, to the real cost of starting as an LLC, to why royalty agreements shape cash flow long after the ink dries. Whether you're a surgeon-innovator weighing your first funding round or an engineer planning a device company's financial architecture, this conversation lays out the structural, financial, and human realities of MedTech financing that most pitch decks never mention. ⏱️ Chapters: 00:00 The Valley of Death in MedTech startups 02:37 Meet the founders, investors, and experts 04:40 Startup runway and burn rate explained 06:04 How venture financing rounds work in MedTech 09:42 Grants vs equity and preserving ownership 11:08 How VC fund lifecycles pressure founders 13:06 Finding investors for hardware medical devices 18:16 LLC vs C corporation and hidden structural costs 22:09 Royalty streams and long-tail financial obligations 24:31 Approach financing like clinical design Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #MedTechStartup #MedicalDeviceFinancing #ValleyOfDeath #VentureCapital #StartupFunding #EquityDilution #RoyaltyAgreements #MedTechInnovation #SurgeonInnovator #FromIdeaToMarket

    28 min

  6. 31/03

    FITM: The Full Conversation with Robert Cohen

    Send us Fan Mail Robert Cohen has spent four decades on both sides of the MedTech table — founding companies, selling them, and now evaluating billion-dollar acquisitions as Stryker's VP of Innovation and Technology for Orthopedics. In this conversation, he shares exactly what a global company looks for when it decides whether a startup's technology is worth acquiring. Cohen's career reads like a timeline of modern orthopedic innovation. He co-founded Implex, the company behind trabecular metal, which was acquired by Zimmer. He then built a 3D printing company that worked closely with Mako Surgical, and when Stryker acquired Mako in what became one of its most successful acquisitions, Cohen came with it — returning to Stryker 23 years after he'd originally left. That rare vantage point, having been the founder pitching and the executive evaluating, shapes every insight in this episode. From the reimbursement pressures reshaping which innovations get funded, to why founder ego can quietly kill an acquisition, to the 15-minute pitch structure that actually gets a company's attention, this is a conversation for anyone building a medical device and wondering what happens when a big company comes knocking. Cohen also looks ahead at where he'd put $10 million today and why the convergence of digital, AI, and enabling technology makes this the most exciting era in orthopedic innovation. ⏱️ Chapters: 00:00 Four decades of MedTech innovation at Stryker 01:29 From startup founder to global acquisition leader 04:29 How Stryker evaluates technology for acquisition 05:38 Reimbursement challenges in medical device innovation 09:35 Assessing MedTech startups at different stages 12:11 Rising patient expectations and implant engineering 15:18 Why C corporation structure matters for startups 17:44 How founder ego affects acquisition negotiations 20:25 What large companies look for in acquisition targets 24:07 Post-acquisition integration and retaining talent 29:08 How Mako changed orthopedic robotics at Stryker 34:36 Where to invest $10 million in MedTech today 38:17 The 15-minute pitch that gets a company's attention Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #RobertCohen #Stryker #MakoRobotics #MedTechStartup #OrthopedicInnovation #MedicalDeviceAcquisition #TrabecularMetal #RoboticSurgery #3DPrinting #TotalJointReplacement #MedTechInvestment

    44 min

  7. 27/03

    The Team Behind the Surgeon: Efficiency Lessons From Canada

    Send us Fan Mail Dr. Sebastian Rodriguez-Elizalde built a same-day anterior hip program inside a Canadian public hospital — not a private surgical center. This conversation covers what it actually takes to change your approach, your team culture, and your system all at once. Sebastian trained in posterior approach at HSS and transitioned to anterior approach early in his independent career. In this episode, he talks honestly about the ego hit of relearning something you were already good at, the anxiety of operating without a safety net, and the decision to go all-in without giving himself the option to retreat. He describes surgery as choreography — a measured cadence where every team member understands the beats of the day. What makes this conversation different is the emphasis on system change. Sebastian didn't just get faster in the OR. He brought his entire team to observe high-efficiency programs run by surgeons like Charlie DeCook and Kristoff Corten, then built a hybrid Canadian model from what everyone learned. He explains how overcoming institutional inertia in a public healthcare system requires patience, proof of concept, and the ability to speak the language of administrators, nurses, and anesthesiologists — not just surgeons. Whether you are early in your career or rethinking how your OR runs, this episode offers a practical blueprint for building something better without burning out. ⏱️ Chapters: 00:00 Introduction and guest background 01:39 Why surgery is like choreography 05:58 Why team rhythm matters more than surgeon speed 08:03 Real constraints of a Canadian public hospital system 10:37 Overcoming institutional inertia to drive change 14:11 Post-fellowship growth and learning to lead system change 16:27 How measuring every surgical step changes your practice 18:41 Switching from posterior to anterior approach mid-career 23:19 Going all-in and what it teaches you about ego 26:00 Why the whole team needs to see high-efficiency surgery 30:09 Mistakes surgeons make building rapid discharge programs 32:04 Three non-negotiables for a high-efficiency OR 36:50 Evaluating new technology when every dollar matters 43:18 Career advice and the five percent growth rule Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #TotalHipReplacement #AnteriorApproach #SameDayHipReplacement #SurgicalEfficiency #RapidDischarge #ORTeamwork #HipArthroplasty #THA #SurgicalEducation #PublicHealthcare #RoboticsInSurgery #SebastianRodriguezElizalde

    53 min

  8. 24/03

    FITM: The Full Conversation with ForCast Orthopedics

    Send us Fan Mail This is a deep-dive extended interview with the team behind ForCast Orthopedics — a company working to change how periprosthetic joint infection is treated. It's for orthopedic surgeons, arthroplasty specialists, and anyone interested in how a clinical idea becomes a medical device company. The conversation brings together Dr. Jared Foran (CSO and co-founder), Dr. Leo Whiteside (the surgeon whose intraarticular infusion technique underlies the product), and Peter Noymer (CEO). Together they trace the origin of the idea from residency-era frustration with antibiotic elution curves, through multiple failed prototypes, to the current catheter-based system designed to make Whiteside's technique practical and scalable. The discussion covers the pharmacokinetic rationale for intraarticular infusion, the clinical and economic case for tackling PJI more aggressively, the regulatory strategy including Orphan Drug and QIDP designations, what it takes to pitch early-stage med tech to investors, and what ForCast's scientific advisory board actually does for product strategy. If you're curious about what a surgeon-founded company looks like from the inside — the pivots, the regulatory burden, the reimbursement complexity, and the moment the team knew the idea was worth building — this is the conversation. Learn more about ForCast Orthopedics: https://forcastortho.com ⏱️ Chapters: 00:00 Introductions 01:44 The clinical origin of the idea 02:57 Why intraarticular infusion works: the pharmacokinetic argument 06:00 What ForCast brought to Leo's technique 07:34 Peter's personal and professional motivation 08:46 The emotional spark that drove Jared to pursue it 10:35 Early questions and challenges developing the technique 13:30 Success rates and the evidence base 14:41 From good idea to viable company: the business case 16:49 Surprising early prototype results and what they revealed 19:15 Common mistakes new innovators make 20:00 How to approach investors before clinical proof exists 22:06 Orphan Drug and QIDP designations explained 25:21 FDA endpoints and what has to be proven 26:08 Balancing regulatory requirements with clinical reality 27:03 How the scientific advisory board shapes product strategy 28:53 What makes surgeons trust or resist a new technology 30:43 Feedback from early adopters 33:05 The kit that surgeons have been waiting for 33:25 The biggest barrier to hospital adoption 35:20 What true success looks like for ForCast 37:20 Timeline for widespread adoption 37:48 The hardest part of the journey 38:18 What "from idea to market" means after living it 39:14 Advice for the surgeon with an idea on a napkin 41:07 What has been most fulfilling 43:20 Closing thoughts Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #ForCastOrthopedics #PeriprostheticJointInfection #PJI #IntraArticularInfusion #MedicalDeviceInnovation #OrthopedicInfection #TotalHipArthroplasty #TotalKneeArthroplasty #ArthroplastyInfection #MedTechStartup #OrphanDrug

    46 min
Ver tudo (65)

Trailers

Sobre

The AHF Podcast features thoughtful conversations about orthopedic surgery, outcomes, and clinical decision-making, with a particular focus on hip surgery and related innovation.Produced by the Anterior Hip Foundation, the podcast brings together surgeons, researchers, and clinical leaders to examine how evidence, experience, and real-world practice intersect. Episodes explore what the data actually shows, where assumptions break down, and how clinicians navigate uncertainty in daily practice.This podcast is intended for orthopedic surgeons, trainees, and medically literate clinicians who value nuanced discussion, critical thinking, and honest examination of what improves patient care.

Informação

  • Autoria
    Anterior Hip Foundation
  • Anos em atividade
    2024 - 2026
  • Episódios
    65
  • Classificação
    Para todos
  • Copyright
    © 2026 Anterior Hip Foundation
  • Site do programa
    AHF Podcast

Talvez também goste